Chembio Diagnostics Inc. (CEMI)

5.70
NASDAQ : Health Technology
Prev Close 5.37
Day Low/High 5.41 / 5.71
52 Wk Low/High 4.39 / 9.90
Avg Volume 45.00K
Exchange NASDAQ
Shares Outstanding 17.57M
Market Cap 94.33M
EPS -0.60
Div & Yield N.A. (N.A)

Latest News

Oversold Conditions For Chembio Diagnostics (CEMI)

Oversold Conditions For Chembio Diagnostics (CEMI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Chembio Diagnostics Is Now Oversold (CEMI)

Chembio Diagnostics Is Now Oversold (CEMI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Chembio Diagnostics Reaches Analyst Target Price

Chembio Diagnostics Reaches Analyst Target Price

In recent trading, shares of Chembio Diagnostics Inc have crossed above the average analyst 12-month target price of $11.17, changing hands for $11.30/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Chembio Diagnostics Announces Completion Of U.S. Clinical Trial Evaluating DPP® HIV-Syphilis System

Chembio Diagnostics Announces Completion Of U.S. Clinical Trial Evaluating DPP® HIV-Syphilis System

U.S. Regulatory Submission for DPP® HIV-Syphilis System Expected in Q1 2018

Chembio Receives $8.5 Million Commitment From Bio-Manguinhos To Purchase Components For Production Of DPP® Assays In Brazil During 2018

Chembio Receives $8.5 Million Commitment From Bio-Manguinhos To Purchase Components For Production Of DPP® Assays In Brazil During 2018

Chembio Receives $4.2 Million in Accounts Receivable Payments from Bio-Manguinhos

Chembio Diagnostics Reports Third Quarter 2017 Financial Results

Chembio Diagnostics Reports Third Quarter 2017 Financial Results

Conference Call and Webcast Today at 4:30 p.m. Eastern Time

Chembio To Host Conference Call To Discuss Third Quarter 2017 Financial Results

Chembio To Host Conference Call To Discuss Third Quarter 2017 Financial Results

Conference Call Scheduled for Wednesday, November 8th at 4:30 p.m. Eastern Time

Chembio Diagnostics Reports Second Quarter 2017 Financial Results

Chembio Diagnostics Reports Second Quarter 2017 Financial Results

Conference Call and Webcast Today at 4:30 p.m. Eastern Time

Chembio To Host Conference Call To Discuss Second Quarter 2017 Financial Results

Chembio To Host Conference Call To Discuss Second Quarter 2017 Financial Results

Conference Call Scheduled for Wednesday, August 9th at 4:30 p.m. Eastern Time

Gail S. Page Joins Chembio Diagnostics Board Of Directors

Gail S. Page Joins Chembio Diagnostics Board Of Directors

Adds Additional Diagnostic Industry Leadership and Healthcare Expertise